Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
SSL Pharma Sciences is a manufacturer of pharmaceutical preparation
Customise key metrics, see detailed forecasts, download stock data and more
A significant proportion of promoter holdings is pledged
In last 3 months, mutual fund holding of the company has almost stayed constant
Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication published on October 22, 2024 the Unaudited Financial Results for the quarter and half year ended September 30, 2024 | Download
Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication published on October 22, 2024 the Unaudited Financial Results for the quarter and half year ended September 30, 2024 | Download
Final • Div/Share: ₹ 3
Increased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 6.78%